EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieKohortenstudieOpen Access

Phenoconversion in pure autonomic failure: a multicentre prospective longitudinal cohort study

Patricio Millar Vernetti iD, Lucy Norcliffe-Kaufmann, Jose-Alberto Palma iD, Italo Biaggioni, Cyndya A Shibao, Amanda Peltier, Roy Freeman, Christopher Gibbons, David S Goldstein iD, Phillip A Low, Wolfgang Singer iD, Elizabeth A Coon iD und 6 weitere

Brain · 2024

DOI: 10.1093/brain/awae033 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Brain, 2024. Verfasst von Patricio Millar Vernetti und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, New York University Grossman School of Medicine, New York, NY 10016, USA. Hauptthemen laut MEDLINE: Pure Autonomic Failure, Parkinson Disease. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIH, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aimed to describe the clinical features of patients with pure autonomic failure (PAF) preceding phenoconversion that could be useful as predictive markers for advancing α-synuclein-associated neurodegeneration of the brain. Patients diagnosed with PAF were evaluated at eight centres (seven US-based and one European) and enrolled in a longitudinal observational cohort study (NCT01799915). Subjects underwent detailed assessments of motor, sleep, olfactory, cognitive and autonomic function and were followed prospectively to determine whether they developed parkinsonism or dementia for up to 10 years. We identified incident cases of Parkinson's disease (PD), dementia with Lewy bodies (DLB) or multiple system atrophy (MSA) and computed hazard ratios for phenoconversion as functions of clinical features. A total of 209 participants with PAF with a median disease duration of 6 years (IQR: 3–10) were enrolled. Of those, 149 provided follow-up information at an office or telemedicine visit. After a mean follow-up duration of 3 years, 48 (33%) participants phenoconverted (42% to PD, 35% to DLB and 23% to MSA). Faster phenoconversion from study enrolment to any diagnosis was associated with urinary and sexual dysfunction [hazard ratio (HR) 5.9, 95% confidence interval (CI): 1.6–22 and HR: 3.6, 95% CI: 1.1–12] followed by subtle motor signs (HR: 2.7, 95% CI: 1.2–6), trouble swallowing (HR 2.5, 95% CI: 1.4–4.5) and changes in speech (HR:2.4, 95% CI:1.1–4.8) at enrolment. Subjects reporting deterioration of handwriting were more likely to phenoconvert to PD (HR: 2.6, 95% CI: 1.1–5.9) and those reporting difficulty handling utensils were more likely to phenoconvert to DLB (HR: 6.8, 95% CI: 1.2–38). Patients with a younger age of PAF onset (HR: 11, 95% CI: 2.6–46), preserved olfaction (HR: 8.7, 95% CI: 1.7–45), anhidrosis (HR: 1.8, 95% CI: 1–3.1, P = 0.042) and severe urinary problems (HR 1.6, 95% CI: 1–2.5, P = 0.033) were more likely to phenoconvert to MSA. The best autonomic predictor of PD was a blunted heart rate increase during the tilt-table test (HR: 6.1, 95% CI: 1.4–26). Patients with PAF have an estimated 12% (95% CI: 9–15%) per year annual risk following study entry of phenoconverting to a manifest CNS synucleinopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pure Autonomic FailureParkinson DiseaseHumansMaleFemaleAgedLongitudinal StudiesMiddle AgedProspective StudiesDisease ProgressionLewy Body DiseaseCohort StudiesMultiple System Atrophy

Stichwörter der Autor:innen

Lewy body diseaseatypical parkinsonismautonomic dysfunctionautonomic failurenatural historyprospective

Autor:innen und Institutionen

  • Department of Neurology, New York University Grossman School of Medicine, New York, NY 10016, USA.
  • Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
  • Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Autonomic Medicine Section, Clinical Neurosciences Program, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
  • Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA 94304, USA.

ORCID-Profile: Patricio Millar Vernetti, Jose-Alberto Palma, David S Goldstein, Wolfgang Singer, Elizabeth A Coon, Mitchell G Miglis, Alessandra Fanciulli, Horacio Kaufmann

Förderung

  • NINDS NIH HHS
  • NIH
  • NHLBI NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • Division of Intramural Research

Zitieren

APA

Millar Vernetti, P., Norcliffe-Kaufmann, L., Palma, J. A., Biaggioni, I., Shibao, C. A., Peltier, A., Freeman, R., Gibbons, C., Goldstein, D. S., Low, P. A., Singer, W., Coon, E. A., Miglis, M. G., Wenning, G. K., Fanciulli, A., Vernino, S., Betensky, R. A., & Kaufmann, H. (2024). Phenoconversion in pure autonomic failure: a multicentre prospective longitudinal cohort study. Brain. https://doi.org/10.1093/brain/awae033

Vancouver

Millar Vernetti P, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Shibao CA, Peltier A, et al. Phenoconversion in pure autonomic failure: a multicentre prospective longitudinal cohort study. Brain. 2024. doi:10.1093/brain/awae033

BibTeX
@article{MillarVernetti2024,
  author = {Millar Vernetti, Patricio and Norcliffe-Kaufmann, Lucy and Palma, Jose-Alberto and Biaggioni, Italo and Shibao, Cyndya A and Peltier, Amanda and Freeman, Roy and Gibbons, Christopher and Goldstein, David S and Low, Phillip A and Singer, Wolfgang and Coon, Elizabeth A and Miglis, Mitchell G and Wenning, Gregor K and Fanciulli, Alessandra and Vernino, Steven and Betensky, Rebecca A and Kaufmann, Horacio},
  title = {Phenoconversion in pure autonomic failure: a multicentre prospective longitudinal cohort study},
  journal = {Brain},
  year = {2024},
  doi = {10.1093/brain/awae033}
}
Kostenlos starten →